Lymphatic Transport of Liposome-Encapsulated Drugs Following Intraperitoneal Administration – Effect of Lipid Composition
- 1 January 1985
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 02 (6) , 271-278
- https://doi.org/10.1023/a:1016337500364
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.The Journal of Pharmacology and Experimental Therapeutics, 1983
- Peritoneal lymphatic uptake of fibrinogen and erythrocytes in the ratAmerican Journal of Physiology-Heart and Circulatory Physiology, 1983
- Carrier Activity of Sonicated Small Liposomes Containing Melphalan to Regional Lymph Nodes of RatsPharmacology, 1983
- Liposomes disposition in vivo V. Liposome stability in plasma and implications for drug carrier functionBiochimica et Biophysica Acta (BBA) - General Subjects, 1982
- COMPARISON OF LYMPHATIC UPTAKE, METABOLISM, EXCRETION, AND BIODISTRIBUTION OF FREE AND LIPOSOME-ENTRAPPED [C-14]LABELED CYTOSINE BETA-D-ARABINOFURANOSIDE FOLLOWING INTRAPERITONEAL ADMINISTRATION TO RATS1982
- INTRALYMPHATIC ADMINISTRATION OF LIPOSOME-ENCAPSULATED DRUGS TO MICE - POSSIBILITY FOR SUPPRESSION OF THE GROWTH OF TUMOR-METASTASES IN THE LYMPH-NODES1981
- Chemotherapy for murine ovarian cancer: a rationale for ip therapy with adriamycin.1979
- PHARMACOKINETIC RATIONALE FOR PERITONEAL DRUG ADMINISTRATION IN TREATMENT OF OVARIAN CANCER1978
- Liposomes as Vehicles for the Local Release of DrugsClinical Science, 1975
- Phosphorus Assay in Column ChromatographyJournal of Biological Chemistry, 1959